OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
63
Results
Show all
Save search
Copy query
Show results for
Unknown
(34)
Metabolomics
(13)
Genomics
(10)
Transcriptomics
(5)
Proteomics
(1)
Organisms
Homo sapiens
(4)
Sus scrofa
(1)
Mus musculus
(1)
Alphavirus
(1)
Anemia
(1)
Betaherpesvirinae
(1)
Brassica oleracea var. oleracea
(1)
Cowpox virus
(1)
Coxsackievirus
(1)
Cytomegalovirus
(1)
Dengue virus
(1)
EFO:0001352
(1)
Filoviridae
(1)
Hepatitis B virus
(1)
Human alphaherpesvirus 1
(1)
Human betaherpesvirus 5
(1)
Human immunodeficiency virus
(1)
Human immunodeficiency virus 1
(1)
Human immunodeficiency virus 2
(1)
Influenza A virus
(1)
Influenza C virus
(1)
Japanese encephalitis virus group
(1)
Lyssavirus rabies
(1)
Monkeypox virus
(1)
Nostoc sp. PCC 7120 = FACHB-418
(1)
Oropouche virus
(1)
Orthopoxvirus
(1)
Orthopoxvirus vaccinia
(1)
Rattus
(1)
Staphylococcus aureus
(1)
Organisms
Homo sapiens
(4)
Sus scrofa
(1)
Mus musculus
(1)
Repository
MetaboLights
(13)
ENA
(9)
geo
(6)
pride
(1)
Tissue
Blood
(1)
Technology Type
Mass spectrometry assay
(8)
Mass spectrometry
(5)
Affinity purification coupled with mass spectrometry proteomics
(1)
Mass Spectrometry
(1)
Instrument Platform
Liquid Chromatography MS - negative - reverse phase
(4)
Liquid Chromatography MS - positive - reverse phase
(4)
Liquid Chromatography MS - alternating - reverse-phase
(2)
Liquid Chromatography MS - positive - reverse-phase
(2)
Liquid Chromatography MS - negative - reverse-phase
(2)
Liquid Chromatography MS - negative - hilic
(2)
Liquid Chromatography MS - positive - hilic
(2)
Liquid Chromatography MS - alternating - c18
(1)
Liquid Chromatography MS - negative - reversed-phase
(1)
Liquid Chromatography MS - positive - reversed-phase
(1)
Gas Chromatography MS - positive
(1)
Liquid Chromatography MS - alternating - hilic
(1)
CHEBI ID
CHEBI:192461
(2)
CHEBI:18193
(2)
CHEBI:138832
(2)
CHEBI:2899
(2)
CHEBI:16220
(2)
CHEBI:6857
(2)
CHEBI:5321
(2)
CHEBI:40
(2)
CHEBI:2522
(2)
CHEBI:139030
(2)
CHEBI:17521
(2)
CHEBI:18152
(2)
CHEBI:75633
(2)
CHEBI:176825
(2)
CHEBI:18026
(2)
CHEBI:48707
(2)
CHEBI:18292
(2)
CHEBI:28327
(2)
CHEBI:38747
(2)
CHEBI:9159
(2)
CHEBI:50202
(2)
CHEBI:28833
(2)
CHEBI:28917
(2)
CHEBI:42255
(2)
CHEBI:17745
(2)
CHEBI:15864
(2)
CHEBI:69187
(2)
CHEBI:30805
(2)
CHEBI:16243
(2)
CHEBI:8113
(2)
Metabolite Name
Toosendanin
(11)
Adenosine
(11)
Creatine
(10)
Oleamide
(9)
Betaine
(8)
4-Hydroxybenzaldehyde
(8)
Creatinine
(8)
L-Tyrosine
(8)
L-Phenylalanine
(8)
Solasodine
(7)
Uracil
(7)
Sphingosine
(7)
Phytosphingosine
(7)
Piperidine
(7)
Daidzein
(7)
L-Threonine
(7)
Pyridoxine
(7)
L-Histidine
(7)
Xanthosine
(7)
Erucamide
(7)
L-Proline
(7)
L-Lysine
(7)
Spermidine
(7)
Riboflavin
(7)
L-Valine
(7)
Caffeine
(7)
Hypoxanthine
(7)
Solanidine
(6)
Chlorobenzene
(6)
Diacetoxyscirpenol
(6)
First Public Date
2025
(2)
2023
(2)
2022
(2)
2026
(1)
2024
(1)
2020
(1)
Release Date
2022
(7)
2017
(5)
2023
(4)
2018
(3)
2016
(3)
2025
(2)
2024
(2)
2021
(2)
2019
(2)
2020
(1)
2015
(1)
2012
(1)
2009
(1)
Lab affiliation
Department of Radiation Oncology, Univerisity of Pennsylvania
(1)
Publication date
2026
(9)
2025
(4)
2022
(3)
2024
(2)
2020
(1)
2023
(1)
Tags
xref:PubMed:42218538
(1)
xref:PubMed:36110293
(1)
xref:PubMed:36791206
(1)
Previous
page
1 / 7
You're on page
1
page
2
page
3
page
4
page
5
page
6
page
7
Next
page
Sort
by:
Relevance
Page size
10
Effect of Toosendanin on mRNA m6A Modification and Expression in Human hepatoma cell line HepG2
Effect of Toosendanin on mRNA m6A Modification and Expression in Human hepatoma cell line HepG2
PRJNA1153488
|
ENA
Cite
Effect of Toosendanin on mRNA m6A Modification and Expression in Human hepatoma cell line HepG2
mRNA-seq and high throughput MeRIP-seq methods with bioinformatics analysis demonstrated a possible mechanism for the inhibition of cell cycle of hepatoma HepG2 cells induced by toosendanin.
ORGANISM(S):
Homo sapiens
2025-08-26
|
GSE275885
|
GEO
Cite
Screening of a Small Molecule Compound Library Identifies Toosendanin as an Inhibitor Against Bunyavirus and SARS-CoV-2.
Not available
S-EPMC8632254
|
biostudies-literature
Cite
The effects of toosendanin against Spodoptera frugiperda larvae
PRJNA954990
|
ENA
Cite
Toosendanin, a novel potent vacuolar-type H
+
-translocating ATPase inhibitor, sensitizes cancer cells to chemotherapy by blocking protective autophagy.
Not available
S-EPMC9066121
|
biostudies-literature
Cite
Transcriptome analysis of toosendanin (TSN)-treated macrophages
Transcriptome analysis of toosendanin (TSN)-treated macrophages
PRJNA804920
|
ENA
Cite
Toosendanin targeting eEF2 impedes Topoisomerase I & II protein translation to suppress esophageal squamous cell carcinoma growth.
Not available
S-EPMC10124032
|
biostudies-literature
Cite
The effects of toosendanin on the larval midgut of Spodoptera frugiperda
PRJNA982549
|
ENA
Cite
Transcriptome analysis of toosendanin (TSN)-treated DLBCL cells
Transcriptome analysis of toosendanin (TSN)-treated DLBCL cells
PRJNA1130884
|
ENA
Cite
Toosendanin demonstrates promising antitumor efficacy in osteosarcoma by targeting STAT3.
Not available
S-EPMC5702716
|
biostudies-literature
Cite
Previous
page
1 / 7
You're on page
1
page
2
page
3
page
4
page
5
page
6
page
7
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
